ANIK

Anika Therapeutics Inc.

Price

$21.26

return (12m)

147.50%

p/e

-74.50

p/bv

2.06

DIVIDEND YIELD

0.00%

ANIK price

Anika Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ANIK

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

38.86%

3 months

41.54%

1 year

147.50%

2 years

-20.52%

5 years

-50.62%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ANIK

Valuation

P/E

-74.50

Sector -4.38

Industry -4.38

P/BV

2.06

Sector 2.02

Industry 2.02

P/Revenue (PSR)

2.34

Sector -4.40

Industry -4.40

EV/EBITDA

54.70

Sector -263.09

Industry -263.09

EV/EBIT

82.69

Sector -702.90

Industry -702.90

P/EBITDA

553.65

Sector -4.39

Industry -4.39

P/EBIT

-55.15

Sector -4.73

Industry -4.73

P/Total Assets

1.54

Sector 1.49

Industry 1.49

P/Net Current Assets

5.33

Sector -11.70

Industry -11.70

P/Working Capital

3.67

Sector -3.19

Industry -3.19

EPS

-0.29

Sector -2.14

Industry -2.14

BVPS

10.56

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

62.16%

Sector 36.74%

Industry 36.74%

EBITDA Margin

13.68%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

9.05%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-4.24%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-3.14%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.18

Sector 0.03

Industry 0.03

Profitability

ROE

-2.76%

Sector -65.14%

Industry -65.14%

ROA

-2.07%

Sector -65.53%

Industry -65.53%

ROIC

8.71%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.48

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-8.61

Sector -6.07

Industry -6.07

Net Debt / EBIT

-13.02

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.28

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.00

Sector -0.05

Industry -0.05

Equity/Assets

0.75

Sector 0.41

Industry 0.41

Liabilities/Assets

0.25

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-3.98%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ANIK

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ANIK Anika Therapeutics Inc.	$21.26	147.50%	0.00%	-74.50	2.06	-2.76%	-3.14%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ANIK Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Anika Therapeutics

Anika Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

34 years

Founded: 1992

1993

Time since IPO - 33 years

154

Employees

Anika Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $282.36 million, with shareholders equity totaling $137.28 million.

The company employs approximately 154 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Anika Therapeutics Inc. reported $120.65 million in revenue, generating net income of $-3.79 million.

Key financial metrics include a P/E ratio of -74.50, a price-to-book (P/B) ratio of 2.06, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ANIK.

Market cap

$282.36 million

Net worth

$137.28 million

$137,280,000.00

Assets

$183.47 million

$183,470,000.00

Total Shares Outstanding

13.00 million

13,000,000

Average Daily Trading Volume

$89.21 Thousand

$89,214.60

Sector

Health Care

Industry

Biotechnology

ANIK

ANIK revenue and profits

Financial Results ANIK

DRAG THE FRAME TO SEE MORE DATA

ANIK cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Anika Therapeutics (ANIK) today?

A cotação de Anika Therapeutics (ANIK) hoje está em US$ 21.26, com uma variação de 147.5% em relação ao último ano. A cotação de Anika Therapeutics (ANIK) iniciou o ano negociando na casa dos US$ 9.61 e hoje está em US$ 21.26. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Anika Therapeutics (ANIK) e dados de ações do Ibovespa e mercados internacionais.

Quando Anika Therapeutics (ANIK) paga dividendos?

Anika Therapeutics (ANIK) não distribuiu dividendos no último ano.

Is Anika Therapeutics (ANIK) a good investment?

Atualmente, Anika Therapeutics (ANIK) está cotada a US$ 21.26, com um P/L de -74.50, representando um desvio de -2,502% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 147.5 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 147.50%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Anika Therapeutics (ANIK) stock?

Investir em ações de Anika Therapeutics (ANIK) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Anika Therapeutics (ANIK) yield today?

A rentabilidade de Anika Therapeutics (ANIK) foi de 38.86% no último mês, 147.50% no último ano e -50.62% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Anika Therapeutics (ANIK) hoje, o investimento total seria de US$ 2,126.00, com base na cotação atual de US$ 21.26.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 5,261.85
Em 5 anos: US$ 1,049.82
Em 10 anos: US$ 2,126.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ANIK

Anika Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ANIK

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ANIK WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Anika Therapeutics

Anika Therapeutics Inc.

United States

34 years

1993

154

PROFIT X PRICE ANIK

Financial Results ANIK

ANIK cash flow

Asset, Revenue and Profit Growth - ANIK

ANIK balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions